We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.21B
AUM Growth
+$402M
(+22%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
12.07%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,247
New
172
Increased
894
Reduced
64
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.97M |
| 2 |
Apple
AAPL
|
+$8.92M |
| 3 |
Amazon
AMZN
|
+$8.89M |
| 4 |
Broadcom
AVGO
|
+$8.06M |
| 5 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$3.45M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$3.39M |
| 3 |
MSCI
MSCI
|
+$3.27M |
| 4 |
Broadridge
BR
|
+$3.02M |
| 5 |
MON
Monsanto Co
MON
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 12.6% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
DaVita
DVA
$15.1B
| $562K | 0.03% |
8,093
+2,210
| +38% | +$148K |
|
827
Iron Mountain
IRM
$38.2B
| $558K | 0.03% |
15,950
+5,634
| +55% | +$190K |
|
|
RDC
828
DELISTED
Rowan Companies Plc
RDC
| $558K | 0.03% |
+34,423
| New | +$517K |
|
829
Brown-Forman Class B
BF.B
$12B
| $556K | 0.03% |
11,352
+2,000
| +21% | +$109K |
|
830
J.M. Smucker
SJM
$12.6B
| $553K | 0.03% |
5,147
+868
| +20% | +$97.5K |
|
831
Xylem
XYL
$28.5B
| $553K | 0.03% |
8,212
+1,364
| +20% | +$99K |
|
|
VRE
832
DELISTED
Veris Residential
VRE
| $552K | 0.03% |
27,231
+2,981
| +12% | +$54.9K |
|
833
CenterPoint Energy
CNP
$29.1B
| $551K | 0.02% |
19,880
+3,348
| +20% | +$87.8K |
|
834
Synaptics
SYNA
$4.41B
| $551K | 0.02% |
10,946
+1,806
| +20% | +$81.9K |
|
835
Masco
MAS
$16B
| $550K | 0.02% |
14,707
+2,480
| +20% | +$95.5K |
|
836
C.H. Robinson
CHRW
$22B
| $546K | 0.02% |
6,532
+1,116
| +21% | +$99.6K |
|
837
Cboe Global Markets
CBOE
$29.8B
| $539K | 0.02% |
5,183
+423
| +9% | +$44.7K |
|
838
Arthur J. Gallagher & Co
AJG
$63.7B
| $538K | 0.02% |
8,244
+670
| +9% | +$45.4K |
|
839
PVH
PVH
$3.71B
| $536K | 0.02% |
3,583
+620
| +21% | +$97.6K |
|
840
Federal Realty Investment Trust
FRT
$10.9B
| $533K | 0.02% |
4,210
+1,596
| +61% | +$188K |
|
|
MXIM
841
DELISTED
Maxim Integrated Products
MXIM
| $533K | 0.02% |
9,082
+1,682
| +23% | +$97.9K |
|
842
BioMarin Pharmaceuticals
BMRN
$11.5B
| $532K | 0.02% |
5,652
+1,048
| +23% | +$91.8K |
|
843
POSCO
PKX
$15.8B
| $531K | 0.02% |
+7,164
| New | +$580K |
|
844
Raymond James Financial
RJF
$32.5B
| $531K | 0.02% |
8,919
+693
| +8% | +$43K |
|
|
JWN
845
DELISTED
Nordstrom
JWN
| $530K | 0.02% |
10,232
+5,620
| +122% | +$279K |
|
|
BIG
846
DELISTED
Big Lots, Inc.
BIG
| $528K | 0.02% |
12,636
+1,388
| +12% | +$58.3K |
|
847
Cooper Companies
COO
$13.7B
| $526K | 0.02% |
8,944
+1,488
| +20% | +$85K |
|
848
Hormel Foods
HRL
$13.9B
| $526K | 0.02% |
14,135
+4,192
| +42% | +$150K |
|
|
GRMN
849
Garmin
GRMN
$46.9B
| $524K | 0.02% |
+8,584
| New | +$515K |
|
850
FMC
FMC
$1.42B
| $523K | 0.02% |
6,753
-1,830
| -21% | -$136K |
|
Similar funds
SAM
Pacer Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Pacer Advisors held 1,247 positions worth $2.21B, up 22% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Pacer Advisors deployed $267M of net new capital in Q2 2018, opening 172 new positions and adding to 894 existing holdings. Its largest new stake was Broadcom: 328,700 shares worth $7.98M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Abiomed Inc, an estimated $3.45M trimmed.
- Pacer Advisors's largest Q2 2018 buy was Broadcom: 328,700 shares worth $7.98M.
- Pacer Advisors added most to Microsoft in Q2 2018, an estimated $8.97M increase.
- Pacer Advisors's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $3.45M.
- Pacer Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q2 2018, selling an estimated $3.39M.
- Pacer Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q2 2018.
- Pacer Advisors opened 172 new positions and closed 79 in Q2 2018.
- Pacer Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.
Based on Pacer Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.